Janet S. Butel | Academic Influence

Janet S. Butel's AcademicInfluence.com Rankings

Janet S. Butel

Biology

#6724

World Rank

#9501

Historical Rank

Virology

#161

World Rank

#166

Historical Rank

biology Degrees

Download Badge

Biology

Janet S. Butel's Degrees

PhD Microbiology University of Texas Medical Branch
Bachelors Biology University of Texas at Austin

Similar Degrees You Can Earn

Best Online Bachelor's in Biology

Why Is Janet S. Butel Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Janet S Butel is the Chairman and Distinguished Service Professor in the molecular virology and microbiology department at Baylor College of Medicine. Her area of expertise is on polyomavirus pathogenesis of infections and disease. She has more than 120 publications on PubMed. She also has 6 publications in Nature, which is considered one of the most prestigious science journals. She is a member of 9 different organizations and has 13 honors and awards.

(See a Problem?)

Janet S. Butel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours (1992) (4915)
Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice (1993) (590)
Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen (1984) (516)
DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. (1992) (405)
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. (2000) (356)
Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. (1984) (347)
Hepatitis B Virus X Protein Interferes with Cellular DNA Repair (1998) (272)
Role of simian virus 40 gene A function in maintenance of transformation (1975) (270)
Hepatitis B virus X protein interacts with a probable cellular DNA repair protein (1995) (242)
Cell and molecular biology of simian virus 40: implications for human infections and disease. (1999) (234)
The history of tumor virology. (2008) (219)
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development (2000) (212)
Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. (1995) (209)
Association between simian virus 40 and non-Hodgkin lymphoma (2002) (208)
SV40 and human tumours: myth, association or causality? (2002) (202)
Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice (1990) (200)
Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene (1996) (189)
p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. (1992) (188)
The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. (2003) (171)
Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. (1991) (137)
Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. (2005) (132)
Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. (1972) (119)
The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice (1994) (116)
Subcellular Localization of Simian Virus 40 Large Tumor Antigen (1979) (113)
Response: More About: Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease. (2000) (112)
DIFFERENTIAL EFFECTS OF INHIBITORS ON THE STEPS LEADING TO THE FORMATION OF SV40 TUMOR AND VIRUS ANTIGENS (1965) (110)
Emergent Human Pathogen Simian Virus 40 and Its Role in Cancer (2004) (110)
Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants (1997) (109)
Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene. (1989) (107)
Effects of the Space Flight Environment on the Immune System (2003) (105)
Simian virus 40 in human cancers. (2003) (104)
The Incorporation of SV40 Genetic Material Into Adenovirus 7 AS Measured by Intranuclear Synthesis of SV40 Tumor Antigen (1964) (100)
Tumor suppressor p53 mutations and breast cancer: a critical analysis. (1995) (98)
Antigenic relationship of SV40 early proteins to purified large T polypeptide. (1979) (97)
Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells (1989) (97)
Frequent detection of polyomaviruses in stool samples from hospitalized children. (2005) (93)
SYNTHESIS OF SV40 TUMOR ANTIGEN DURING REPLICATION OF SIMIAN PAPOVAVIRUS (SV40). (1964) (93)
Pathogenesis and management of polyomavirus infection in transplant recipients. (2002) (91)
Serological evidence of SV40 infections in HIV‐infected and HIV‐negative adults (1998) (84)
Natural Isolates of Simian Virus 40 from Immunocompromised Monkeys Display Extensive Genetic Heterogeneity: New Implications for Polyomavirus Disease (1998) (82)
Polyomavirus Shedding in the Stool of Healthy Adults (2009) (80)
Suppression of in vivo tumor formation induced by simian virus 40- transformed cells in mice receiving antiidiotypic antibodies (1985) (80)
The plasma-membrane-associated form of SV40 large tumor antigen: biochemical and biological properties. (1986) (76)
Evidence of SV40 infections in hospitalized children. (1999) (74)
Interaction of a Simian Papovavirus and Adenoviruses I. Induction of Adenovirus Tumor Antigen During Abortive Infection of Simian Cells (1966) (73)
Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins. (1993) (72)
Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product (1983) (72)
Optimal conditions for uptake of exogenous DNA by Chinese hamster lung cells deficient in hypoxanthine-guanine phosphoribosyltransferase. (1975) (69)
Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells (1985) (69)
Detection of BK virus and simian virus 40 in the urine of healthy children (2005) (68)
SV40-adenovirus "hybrid" populations: transfer of SV40 determinants from one type of adenovirus to another. (1965) (68)
Molecular evidence of simian virus 40 infections in children. (1999) (68)
Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. (2003) (66)
Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. (1993) (62)
Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma (1988) (59)
Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans. (1998) (59)
POLYOMAVIRUS SIMIAN VIRUS 40 INFECTION ASSOCIATED WITH NEPHROPATHY IN A LUNG-TRANSPLANT RECIPIENT (2004) (58)
Demonstration of Infectious Deoxyribonucleic Acid in Transformed Cells I. Recovery of Simian Virus 40 from Yielder and Nonyielder Transformed Cells (1972) (56)
Lymphotropism of Merkel Cell Polyomavirus Infection, Nova Scotia, Canada (2010) (56)
Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients (1994) (55)
Variants of Defective Simian Papovavirus 40 (PARA) Characterized by Cytoplasmic Localization of Simian Papovavirus 40 Tumor Antigen (1969) (54)
Comparison of the growth properties in vitro and transplantability of continuous mouse mammary tumor cell lines and clonal derivatives. (1977) (54)
Variation in Properties of Plaque Progeny of PARA (Defective Simian Papovavirus 40)-Adenovirus 7 (1969) (48)
Mammary tumorigenesis in 7,12-dimethybenzanthracene-treated C57BL x DBA/2f F1 mice. (1980) (48)
Comparative analysis of casein synthesis during mammary cell differentiation in collagen and mammary gland development in vivo. (1985) (47)
The effect of arabinofuranosylcytosine on the growth cycle of simian virus 40. (1965) (47)
Simian virus 40 large T antigen and p53 are microtubule-associated proteins in transformed cells. (1991) (46)
Polyomaviruses and human tumors: a brief review of current concepts and interpretations. (1999) (45)
SV40 in human brain cancers and non-Hodgkin's lymphoma (2003) (45)
Association of SV40 large tumor antigen and cellular proteins on the surface of SV40-transformed mouse cells. (1982) (44)
Integrated state of subgenomic fragments of hepatitis B virus DNA in hepatocellular carcinoma from mainland China. (1987) (41)
Immune responses in adult female volunteers during the bed-rest model of spaceflight: antibodies and cytokines. (2008) (41)
Tissue culture adaptation of natural isolates of simian virus 40: changes occur in viral regulatory region but not in carboxy-terminal domain of large T-antigen. (1997) (41)
Identification of a variable region at the carboxy terminus of SV40 large T-antigen. (1996) (40)
Detection and characterization of a glycoprotein encoded by the mouse mammary tumor virus long terminal repeat gene (1991) (40)
The role of high levels of dietary fat in 7,12-dimethylbenzanthracene-induced mouse mammary tumorigenesis: lack of an effect on lipid peroxidation. (1985) (40)
Detection of polyomavirus SV40 in tonsils from immunocompetent children. (2008) (40)
Mitogenic effects of the proto-oncogene and oncogene forms of c-H-ras DNA in human diploid fibroblasts (1986) (38)
Simian virus 40 infection in lymphoproliferative disorders (2003) (37)
Detection of simian virus 40 surface‐associated large tumor antigen by enzyme‐catalyzed radioiodination (1982) (37)
p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro. (1993) (36)
Polyomavirus Infection and Its Impact on Renal Function and Long-term Outcomes After Lung Transplantation (2009) (36)
Differential phosphorylation of cytoplasmic and nuclear variants of simian virus 40 large T antigen encoded by simian virus 40-adenovirus 7 hybrid viruses (1984) (36)
Lymphoproliferative disorders in Costa Rica and simian virus 40. (2005) (36)
Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin's lymphoma. (2005) (36)
Intracellular transport of SV40 large tumor antigen: a mutation which abolishes migration to the nucleus does not prevent association with the cell surface. (1982) (36)
Detection of Mouse Mammary Tumor Virus RNA in BALB/c Tumor Cell Lines of Nonviral Etiologies (1978) (35)
The Clinical Epidemiology of Hodgkin Lymphoma in HIV-Infected Patients in the Highly Active Antiretroviral Therapy (HAART) Era (2003) (35)
Biochemical characterization of nuclear and cytoplasmic forms of SV40 tumor antigens encoded by parental and transport-detective mutant SV40-adenovirus 7 hybrid viruses. (1980) (35)
AIDS-related systemic non-Hodgkin's lymphoma at a large community program. (2002) (35)
Patterns of polyomavirus SV40 infections and associated cancers in humans: a model. (2012) (34)
Characterization of simian cells tranformed by temperature-sensitive mutants of simian virus 40 (1976) (34)
SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma. (2007) (34)
A prospective longitudinal study of polyomavirus shedding in lung-transplant recipients. (2007) (33)
Simian virus 40 regulatory region structural diversity and the association of viral archetypal regulatory regions with human brain tumors. (2001) (33)
Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice. (1984) (32)
Conventional epidemiology and the link between SV40 and human cancers. (2003) (32)
Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy (2003) (31)
Identification of a conserved sequence in the non-coding regions of many human genes. (1989) (31)
Role of the simian virus 40 gene A product in regulation of DNA synthesis in transformed cells (1978) (30)
Transformation of primate and rodent cells by temperature-sensitive mutants of SV40. (1975) (30)
Simian virus 40, poliovirus vaccines, and human cancer: research progress versus media and public interests. (2000) (30)
Apolipoprotein B gene regulatory factor-2 (BRF-2) is structurally and immunologically highly related to hepatitis B virus X associated protein-1 (XAP-1). (1997) (30)
Consideration of PCR methods for the detection of SV40 in tissue and DNA specimens. (1998) (30)
Inhibition of nuclear migration of wild-type SV40 tumor antigen by a transport-defective mutant of SV40-adenovirus 7 hybrid virus. (1980) (29)
Structural comparisons of wild-type and nuclear transport-defective simian virus 40 large tumor antigens. (1984) (29)
Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance. (2012) (28)
Protection of Measles Virus by Sulfate Ions Against Thermal Inactivation (1965) (28)
Antigenic structure of simian virus 40 large tumor antigen and association with cellular protein p53 on the surfaces of simian virus 40-infected and -transformed cells (1984) (27)
Transformation of mouse mammary epithelial cells by papovavirus SV40. (1984) (27)
Is the DNA repair system involved in hepatitis-B-virus-mediated hepatocellular carcinogenesis? (1996) (27)
Detection of Polyomavirus Simian Virus 40 Tumor Antigen DNA in AIDS‐Related Systemic Non‐Hodgkin Lymphoma (2002) (27)
Replication in Simian Cells of Defective Viruses in an SV40-Adenovirus “Hybrid” Population (1966) (27)
Differential response of cultured mouse mammary cells of varying tumorigenicity to cytochalasin B. (1978) (26)
Temperature-Sensitive Mutants of Simian Virus 40 (1978) (25)
Expression of MDM2 during mammary tumorigenesis (1999) (25)
SV40 and Human Tumors (2002) (25)
Phylogenetic Analysis of Polyomavirus Simian Virus 40 from Monkeys and Humans Reveals Genetic Variation (2004) (25)
SV40-positive brain tumor in scientist with risk of laboratory exposure to the virus (2004) (25)
Mouse mammary tumor virus genome expression in chemical carcinogen-induced mammary tumors in low- and high-tumor-incidence mouse strains. (1979) (23)
Investigations on etiology of Crohn's disease (1991) (23)
Construction of SV40 deletion mutants and delimitation of the binding domain for heat shock protein to the amino terminus of large T-antigen. (1994) (23)
The role of SV40 gene A in the alteration of microfilaments in transformed cells. (1977) (23)
A system for the analysis of BKV non-coding control regions: application to clinical isolates from an HIV/AIDS patient. (2010) (23)
Artificial modification of the viral regulatory region improves tissue culture growth of SV40 strain 776. (1995) (23)
Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects (2016) (23)
Detection of a complex of SV40 large tumor antigen and 53K cellular protein on the surface of SV40‐transformed mouse cells (1982) (22)
Surface T-antigen expression in simian virus 40-transformed mouse cells: correlation with cell growth rate (1985) (21)
Dynamic nature of the association of large tumor antigen and p53 cellular protein with the surfaces of simian virus 40-transformed cells (1984) (21)
Partial Expression of Endogenous Mouse Mammary Tumor Virus in Mammary Tumors Induced in BALB/c Mice by Chemical, Hormonal, and Physical Agents (1981) (21)
Cytotoxic T lymphocyte recognition sequences as markers for distinguishing among tumour antigens encoded by SV40, BKV and JCV. (1998) (21)
Differential ability of two simian virus 40 strains to induce malignancies in weanling hamsters. (2004) (20)
Variation in properties of SV40-transformed simian cell lines detected by superinfection with SV40 and human adenoviruses. (1971) (20)
Cell transformation by viruses (1971) (20)
Detection of antibodies to polyomavirus SV40 in two central European countries. (2003) (20)
Viral MicroRNA Effects on Pathogenesis of Polyomavirus SV40 Infections in Syrian Golden Hamsters (2014) (20)
Differential expression of poly(A)-adjacent sequences of mammary tumor virus RNA in murine mammary cells. (1978) (19)
Properties of transformed hamster cells containing sv40 tumor antigen in the cytoplasm (1971) (19)
Quantification of vertical transmission of Murine polyoma virus by real-time quantitative PCR. (2005) (19)
p53 Mutations in COMMA-D cells (1994) (19)
Tumorigenesis in transgenic mice by a nuclear transport-defective SV40 large T-antigen gene. (1987) (18)
SV40 T‐Antigen as a Dual Oncogene: Structure and Function of the Plasma Membrane‐Associated Population a (1989) (18)
Wnt-1 and int-2 mammary oncogene effects on the β-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis (2001) (18)
Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters. (2009) (18)
Effects of radiation and latent virus on immune responses in a space flight model. (2005) (18)
A coupled PCR and restriction digest method for the detection and analysis of the SV40 regulatory region in infected-cell lysates and clinical samples. (1997) (18)
SV40 lymphomagenesis in Syrian golden hamsters. (2009) (18)
Antigenic analysis of tumors and sera from aimals inoculated with para-adenovirus populations. (1966) (17)
Thrombocytopenia. A complication of mumps. (1974) (17)
Complementation between a defective monkey cell-adapting component and human adenoviruses in simian cells. (1967) (17)
Differential expression of endogenous mouse mammary tumor virus genes during development of the BALB/c mammary gland (1986) (17)
Effect of nuclear localization of large tumor antigen on growth potential of SV40-transformed cells. (1981) (17)
Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX. (2009) (17)
Correlation of surface fucopeptide patterns with tumorigenicity of mouse mammary epithelial cells. (1981) (16)
Detection of Biologically Active Adenovirions Unable to Plaque in Human Cells (1966) (16)
Hepatitis B virus and hepatocellular carcinoma. (1992) (16)
Mouse mammary tumor virus DNA methylation: tissue-specific variation. (1984) (15)
Increasing Evidence for Involvement of SV40 in Human Cancer (2002) (14)
SV40 large T-antigen: dual oncogene. (1986) (14)
SV40 and human mesothelioma (2020) (14)
Influence of the Viral Regulatory Region on Tumor Induction by Simian Virus 40 in Hamsters (2007) (14)
Expression of the mouse mammary tumor virus long terminal repeat open reading frame promotes tumorigenic potential of hyperplastic mouse mammary epithelial cells. (1995) (14)
Polyomavirus SV40 infections in Kazakhstan. (2005) (14)
Spontaneous progression of hyperplastic outgrowths of the D1 lineage to mammary tumors: Expression of mouse mammary tumor virus and cellular proto‐oncogenes (1989) (14)
Inactivation and density studies with PARA-adenovirus 7 (SV40-adenovirus "hybrid" population). (1966) (14)
Ethnic differences in polyomavirus simian virus 40 seroprevalence among women in Houston, Texas. (2013) (13)
Molecular characterization of SV40 DNA in multiple samples from a human mesothelioma. (2000) (13)
Neutralizing and IgG Antibodies against Simian Virus 40 in Healthy Pregnant Women in Italy (2014) (12)
Comparison of ability of defective foreign genomes (PARA and MAC) carried by human adenoviruses to induce SV40 transplantation immunity. (1967) (12)
Polyomavirus SV40: Model Infectious Agent of Cancer (2012) (12)
Clonal populations of the mouse mammary cell line, COMMA-D, which retain capability of morphogenesis in vivo (1989) (12)
Molecular basis of altered mouse mammary tumor virus expression in the D-2 hyperplastic alveolar nodule line of BALB/c mice. (1985) (12)
Effects of radiation and latent virus on immune responses in a space flight model (2005) (12)
Detection of authentic SV40 DNA sequences in human brain and bone tumours. (1998) (11)
Analysis of pp60c-src protein kinase activity in hamster embryo cells transformed by simian virus 40, human adenoviruses, and bovine papillomavirus 1 (1986) (11)
Association Between SV40 and Non-Hodgkin's Lymphoma (2003) (11)
SV40 large T antigen directed by regulatory elements of the human alpha-1-antitrypsin gene. A transgenic mouse system that exhibits stages in liver carcinogenesis. (1990) (11)
Replicative functions of the SV40(cT)-3 mutant defective for nuclear transport of T antigen. (1985) (11)
Influence of mammary cell differentiation on the expression of proteins encoded by endogenous BALB/c mouse mammary tumor virus genes. (1990) (11)
Induction of common transplantation antigen by various isolates of papovavirus SV40 and by virus rescued from transformed cells. (1973) (11)
Simian virus 40 and its association with human lymphomas (2003) (11)
Recent advances in molecular pathology. The state of the viral genome in cells transformed by simian virus 40: a review. (1972) (11)
Complete genomic sequence of a new Human polyomavirus 9 strain with an altered noncoding control region (2014) (11)
Polyomaviruses in solid-organ transplant recipients. (2002) (10)
p53 mutations in mouse mammary epithelial cells: instability in culture and discordant selection of mutations in vitro versus in vivo. (1993) (10)
Naturally Arising Strains of Polyomaviruses with Severely Attenuated MicroRNA Expression (2014) (10)
Papovavirus structural polypeptides: comparison of human and rabbit papilloma viruses with simian virus 40. (1974) (10)
The solubility characteristics of SV 40 tumor antigen. (1976) (9)
The cellular secretory pathway is not utilized for biosynthesis, modification, or intracellular transport of the simian virus 40 large tumor antigen (1987) (9)
Malignant transformation in vitro by "non-oncogenic" variants of defective SV40 (PARA). (1971) (9)
Differential effects of the simian virus 40 early genes on mammary epithelial cell growth, morphology, and gene expression. (1992) (9)
Absence of a structural basis for intracellular recognition and differential localization of nuclear and plasma membrane-associated forms of simian virus 40 large tumor antigen (1986) (8)
Induction of cellular DNA synthesis by a simian virus 40 mutant defective in nuclear transport of T antigen (1985) (8)
Loss of T-antigen sequences allows SV40-transformed human cells in crisis to acquire a senescent-like phenotype. (1997) (8)
Exogenous and Endogenous Mouse Mammary Tumor Viruses: Replication and Cell Transformation (1987) (8)
High-fidelity PCR amplification of infectious copies of the complete simian virus 40 genome from plasmids and virus-infected cell lysates. (1997) (8)
Activation of the HTLV-I long terminal repeat by the hepatitis B virus X protein. (1996) (7)
Epitope mapping and conformational analysis of SV40 T-antigen deletion mutants. (1992) (7)
Fecal Polyomavirus Excretion in Infancy. (2016) (7)
Evidence of simian virus 40 exposure in a colony of captive baboons. (2008) (7)
PCR Detection and DNA Sequence Analysis of the Regulatory Region of Lymphotropic Papovavirus in Peripheral Blood Mononuclear Cells of an Immunocompromised Rhesus Macaque (2002) (7)
SV40 and human brain tumors. (1997) (6)
Correlation between Complement-fixing Cell Antibody and Immunofluorescent Nuclear Antibody in Hamsters bearing ‘SV40’-induced Tumours (1965) (6)
Bed rest and immunity (2007) (6)
Solubilization of SV40 Plasma‐Membrane‐Associated Large Tumor Antigen Using Single‐Phase Concentrations of 1‐Butanol (1989) (6)
Correlation of amino acid fucoside labeling patterns with tumorigenicity of mouse mammary epithelial cells. (1983) (6)
Temperature-sensitive mutants of simian virus 40. I. Isolation aand preliminary characterization of B/C gene mutants. (1978) (6)
Biochemical properties of SV40 large tumor antigen as a glycosylated protein. (1988) (5)
Chromosomal changes in Syrian hamster cells transformed by simian virus 40 (SV40) and variants of defective SV40 (PARA). (1971) (5)
SV40 seroprevalence in two Latin American countries involved in field trials of candidate oral poliovaccines. (2019) (5)
Identification and characterization of a mouse mammary tumor virus protein uniquely expressed on the surface of BALB/cV mammary tumor cells (1985) (5)
Demonstration of infectious DNA in transformed cells. III. Correlation of detection of infectious DNA-protein complexes with persistence of virus in simian adenovirus SA7-induced tumor cells. (1975) (5)
Mammary preneoplasia and tumorigenesis in the BALB/c mouse: structure and modification of mouse mammary tumor virus DNA sequences. (1987) (5)
Characterization of a temperature-sensitive mutant of human adenovirus type 7 (1977) (5)
Characterization of the Strain of Adenovirus Type 7 Carrying the Defective Monkey Cell-adapting Component (1967) (5)
Fluctuation of simian virus 40 (SV40) super T-antigen expression in tumors induced by SV40-transformed mouse mammary epithelial cells (1986) (5)
Effect of dexamethasone on expression of endogenous mouse mammary tumor virus sequences in BALB/c tumor cell lines. (1979) (4)
Infrequent p 53 Mutations in 7 , 12-Dimethylbenz [ a ] anthracene-Induced Mammary Tumors in BALB / cand p 53 Hemizygous Mice (2007) (4)
The Importance of Matrix Interactions and Tissue Topography for the Growth and Differentiation of Mammary Epithelial Cells in Vitro (1986) (4)
Genomic organization of the simian virus 40-adenovirus 7 hybrid virus, PARA(cT), that encodes a nuclear transport defective simian virus 40 T antigen. (1986) (4)
Viral co-factors in liver cancer: lessons from hepatitis B virus. (1995) (4)
Viral microRNA effects on persistent infection of human lymphoid cells by polyomavirus SV40 (2018) (4)
Transformation by viruses: simian virus 40 as a model system. (1978) (3)
Effects of route of inoculation and viral genetic variation on antibody responses to polyomavirus SV40 in Syrian golden hamsters. (2012) (3)
SV 4 O-ADENOVIRUS " HYBRID " POPULATIONS : TRANSFER OF SV 40 DETERMINANTS FROM ONE TYPE OF ADENOVIRUS TO ANOTHER * BY (3)
Predictors of immune function in space flight (2007) (3)
Polyomavirus SV40 infection and lymphomas in Spain (2003) (3)
Infectious DNA-protein complex from cells productively infected with simian adenovirus SA7. (1974) (3)
Mammary cancer stages in BALB/cV mice: mouse mammary tumor virus expression and virus-host interactions. (1987) (3)
15 SV 40 Tumor Antigen Importance of Cell Surface Localization in Transformation and Immunological Control of Neoplasia (1987) (3)
Polyomavirus SV40 and AIDS-related systemic non-Hodgkin's lymphoma. (2007) (2)
SYNTHESIS OF SV 40 TUMOR ANTIGEN DURING REPLICATION OF SIMIAN (2003) (2)
Replication of defective simian virus 40 and a monkey cell-adapting component in human kidney cells (1968) (2)
Can SV40 infect and immortalize human B-lymphocytes and mesothelial cells as a natural pathogen? (2013) (2)
Detection of retroviral superantigen and products of the envelope gene from endogenous mouse mammary tumor virus in B cells from BALB/c mice. (1995) (2)
Genetic evidence for a temperature-sensitive lesion in the adenovirus 7 region of the PARA genome. (1978) (1)
Transfection of mouse mammary epithelial cells (2000) (1)
The role of SV40 viral genes in cellular transformation. (1975) (1)
Neurologic tumors in offspring after inoculation of mothers with killed-poliovirus vaccine. (1988) (1)
Advances in Brief p 53 Mutations Cluster at Codon 249 in Hepatitis B Virus-positive Hepatocellular Carcinomas from China 1 (2006) (1)
Polyomaviruses in Kidney Transplant Recipients (2002) (1)
Demonstration of infectious DNA in transformed cells (1975) (1)
Spaceflight conditions alter human immunity and predispose to infection and cancer (2002) (1)
Variation in Response of Syrian Hamster Lung Cells to Complete or Defective SV40 (PARA) 1 (1970) (1)
SIMIAN VIRUS 40 (PAPOVAVIRIDAE) (1999) (1)
THE INCORPORATION OF SV40 MATERIAL INTO ADENOVIRUS 7 AS MEASURED BY INTRANUCLEAR SYNTHESIS OF SV40 TUMOR ANTIGEN. (1964) (1)
An overview of HIV infection (1990) (1)
Re: Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. (2003) (1)
CHAPTER 2 – DNA Transfer and Virus-Cell Relationships (1974) (1)
Properties of cells transformed by DNA tumor viruses (1975) (1)
Effect of adenovirus type 12 on tumor induction by SV40 and para (defective SV40) (1971) (1)
Hepatitis B Virus Integration Event in Human Chromosome 17p near the p53 Gene Identifies the Region of the Chromosome Commonly Deleted in Virus-positive Hepatocellular Carcinomas1 (2006) (0)
MammaryTumorigenesisin 7,12-Dimethybenzanthracene-treated C57BL x DBA/2f F1Mice1 (1980) (0)
Mutations in Mouse Mammary Epithelial Cells : Instability in Culture and Discordant Selection of Mutations in Vitro . Cl versus in Vivo (2005) (0)
Latent Viruses: A Space Travel Hazard?? (1999) (0)
Immune Function and Reactivation of Latent Viruses (1999) (0)
Re: Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. (2003) (0)
Advances in Brief p53 Mutations Cluster at Codon 249 in Hepatitis B Virus-positive Hepatocellular Carcinomas from China1 (2006) (0)
Immune deficiencies , infection , and systemic immune disorders Immune responses in adult female volunteers during the bedrest model of spaceflight : Antibodies and cytokines (2009) (0)
Biological and biophysical characterization of SV 40 cytoplasmic T-antigen-inducing mutants of PARA-adenovirus 7 (2005) (0)
Altered intracellular transport of exogenous DNA by murine mammary tumor cell lines. (1977) (0)
Necessary for Establishment of Mammary Cell Lines Epithelial Cells Form Hyperplastic Outgrowths Are Not When Mouse Mammary in Vivo Mutations Selected p 53 Updated (2006) (0)
Scientific Contributions of Fred Rapp (1990) (0)
Comment on: Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. Authors' reply (2003) (0)
Characterization of a 7,12-dimethylbenz(α)anthracene-induced BALB/c mouse mammary tumor epithelial cell line (1980) (0)
Re: Lack of serologic evidence for prevalent simian virus 40 infection in humans. (2004) (0)
POLYOMAVIRUS SV 40 AND AIDS-RELATED SYSTEMIC NON-HODGKIN ’ S LYMPHOMA (0)
Detection of Polyomviruses in Tonsils from Healthy Children (2008) (0)
Complete genomic sequence of a new Human polyomavirus 9 strain with an altered noncoding control region (2014) (0)
An overview of the biology and viral pathogenesis of lymphoproliferative disorders in HIV-infected patients. (2003) (0)
Systemic non-Hodgkin's lymphoma in persons with HIV infection. (2000) (0)
Association of simian virus 40 (SV40) with pediatric renal disease (2002) (0)
Effect of Deoxyribonucleia : Acid Anlagonisls (2003) (0)
TheCellular Secretory Pathway IsNotUtilized forBiosynthesis, Modification, orIntracellular Transport oftheSimianVirus40 LargeTumorAntigen (1987) (0)
Tumor cell lines of nonviral etiologies. (1978) (0)
Cellular Protein with the Surfaces of Simian Virus 40-Transformed (0)
Response to more about: cell and molecular biology of simian virus 40: implications for human infections and disease. (2000) (0)

This paper list is powered by the following services:

Other Resources About Janet S. Butel

en.wikipedia.org

What Schools Are Affiliated With Janet S. Butel?

Janet S. Butel is affiliated with the following schools: